• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒肺炎与心血管系统:全面综述。

COVID-19 and cardiovascular system-a comprehensive review.

机构信息

Department of Paediatric Dentistry and Orthodontic Sciences, College of Dentistry, King Khalid University, 62529 Abha, Kingdom of Saudi Arabia.

Department of Diagnostic Dental Sciences, College of Dentistry, King Khalid University, 62529 Abha, Kingdom of Saudi Arabia.

出版信息

Rev Cardiovasc Med. 2021 Jun 30;22(2):343-351. doi: 10.31083/j.rcm2202041.

DOI:10.31083/j.rcm2202041
PMID:34258902
Abstract

Coronavirus disease 2019 (COVID-19), a mystified cryptic virus has challenged the mankind that has brought life to a standstill. Catastrophic loss of life, perplexed healthcare system and the downfall of global economy are some of the outcomes of this pandemic. Humans are raging a war with an unknown enemy. Infections, irrespective of age and gender, and more so in comorbidities are escalating at an alarming rate. Cardiovascular diseases, are the leading cause of death globally with an estimate of 31% of deaths worldwide out of which nearly 85% are due to heart attacks and stroke. Theoretically and practically, researchers have observed that persons with pre-existing cardiovascular conditions are comparatively more vulnerable to the COVID-19 infection. Moreover, they have studied the data between less severe and more severe cases, survivors and non survivors, intensive care unit (ICU) patients and non ICU patients, to analyse the relationship and the influence of COVID-19 on cardiovascular health of an individual, further the risk of susceptibility to submit to the virus. This review aims to provide a comprehensive particular on the possible effects, either direct or indirect, of COVID-19 on the cardiovascular heath of an individual.

摘要

2019 年冠状病毒病(COVID-19)是一种神秘的病毒,它使人类陷入停顿。灾难性的生命损失、困惑的医疗保健系统和全球经济的崩溃是这场大流行的一些后果。人类正在与一个未知的敌人作战。感染,无论年龄和性别,尤其是在合并症中,以惊人的速度升级。心血管疾病是全球死亡的主要原因,全球有 31%的死亡归因于此,其中近 85%是由于心脏病发作和中风。从理论和实践上,研究人员已经观察到,患有先前存在的心血管疾病的人更容易受到 COVID-19 感染。此外,他们研究了轻症和重症病例、幸存者和非幸存者、重症监护病房(ICU)患者和非 ICU 患者之间的数据,以分析 COVID-19 对个人心血管健康的影响,以及个体对病毒的易感性的风险。这篇综述旨在提供关于 COVID-19 对个体心血管健康可能产生的直接或间接影响的全面概述。

相似文献

1
COVID-19 and cardiovascular system-a comprehensive review.新型冠状病毒肺炎与心血管系统:全面综述。
Rev Cardiovasc Med. 2021 Jun 30;22(2):343-351. doi: 10.31083/j.rcm2202041.
2
Covid-19 and the cardiovascular system: a comprehensive review.Covid-19 与心血管系统:全面综述。
J Hum Hypertens. 2021 Jan;35(1):4-11. doi: 10.1038/s41371-020-0387-4. Epub 2020 Jul 27.
3
Interplay of COVID-19 and cardiovascular diseases in Africa: an observational snapshot.非洲 COVID-19 与心血管疾病的相互作用:观察性快照。
Clin Res Cardiol. 2020 Dec;109(12):1460-1468. doi: 10.1007/s00392-020-01720-y. Epub 2020 Aug 18.
4
Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science.新型冠状病毒肺炎中的血管内皮功能障碍:欧洲心脏病学会动脉粥样硬化和血管生物学工作组以及欧洲心脏病学会心血管基础科学理事会立场文件。
Cardiovasc Res. 2020 Dec 1;116(14):2177-2184. doi: 10.1093/cvr/cvaa230.
5
Involvement of cardiovascular system as the critical point in coronavirus disease 2019 (COVID-19) prognosis and recovery.心血管系统参与 2019 冠状病毒病(COVID-19)预后和恢复的关键。
Hellenic J Cardiol. 2020 Nov-Dec;61(6):381-395. doi: 10.1016/j.hjc.2020.05.004. Epub 2020 Jun 10.
6
Covid and Cardiovascular Diseases: Direct and Indirect Damages and Future Perspective.新冠病毒与心血管疾病:直接与间接损害及未来展望
High Blood Press Cardiovasc Prev. 2021 Sep;28(5):439-445. doi: 10.1007/s40292-021-00464-8. Epub 2021 Jun 26.
7
Coronavirus disease 2019 infection and the cardiovascular system.2019冠状病毒病感染与心血管系统
J Cardiovasc Med (Hagerstown). 2020 Jun;21(6):403-405. doi: 10.2459/JCM.0000000000000980.
8
An Overview on COVID-19 and its Effect on Cardiovascular Diseases.关于 COVID-19 及其对心血管疾病影响的概述。
Endocr Metab Immune Disord Drug Targets. 2021;21(11):1949-1953. doi: 10.2174/1871530321999201228214718.
9
A novel coronavirus meets the cardiovascular system: Society for Cardiovascular Pathology Symposium 2021.一种新型冠状病毒与心血管系统的相遇:2021年心血管病理学会研讨会
Cardiovasc Pathol. 2021 Jul-Aug;53:107336. doi: 10.1016/j.carpath.2021.107336. Epub 2021 Apr 23.
10
Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities.男性 COVID-19 死亡率较高:免疫反应和心血管合并症的性别差异。
Cardiovasc Res. 2020 Dec 1;116(14):2197-2206. doi: 10.1093/cvr/cvaa284.

引用本文的文献

1
Impact of the COVID-19 pandemic on initiation of antihypertensive drugs in Sweden: an interrupted time series study.COVID-19 大流行对瑞典开始使用抗高血压药物的影响:一项中断时间序列研究。
BMJ Open. 2024 Oct 16;14(10):e082209. doi: 10.1136/bmjopen-2023-082209.
2
Phenotype clustering of hospitalized high-risk patients with COVID-19 - a machine learning approach within the multicentre, multinational PCHF-COVICAV registry.COVID-19 住院高危患者表型聚类 - 多中心、多国 PCHF-COVICAV 登记处的机器学习方法。
Cardiol J. 2024;31(4):512-521. doi: 10.5603/cj.98489. Epub 2024 Jun 4.
3
Risk and protective factors for Long COVID in Brazilian adults (CUME Study).
巴西成年人长期新冠的风险和保护因素(CUME研究)。
Front Med (Lausanne). 2024 Feb 21;11:1344011. doi: 10.3389/fmed.2024.1344011. eCollection 2024.
4
High AST/ALT Ratio Is Associated with Cardiac Involvement in Acute COVID-19 Patients.AST/ALT 比值高与急性 COVID-19 患者的心脏受累有关。
Medicina (Kaunas). 2023 Jun 16;59(6):1163. doi: 10.3390/medicina59061163.
5
The RAAS Axis and SARS-CoV-2: From Oral to Systemic Manifestations.RAAS 轴与 SARS-CoV-2:从口腔表现到全身表现。
Medicina (Kaunas). 2022 Nov 24;58(12):1717. doi: 10.3390/medicina58121717.
6
Remdesivir-induced Bradycardia is not Associated with Worse Outcome in Patients with COVID-19: A Retrospective Analysis.瑞德西韦引起的心动过缓与 COVID-19 患者的不良结局无关:一项回顾性分析。
Am J Cardiovasc Drugs. 2022 Nov;22(6):705-710. doi: 10.1007/s40256-022-00547-4. Epub 2022 Aug 25.
7
A review on therapeutical potential of paeonol in atherosclerosis.丹皮酚在动脉粥样硬化中的治疗潜力综述。
Front Pharmacol. 2022 Aug 4;13:950337. doi: 10.3389/fphar.2022.950337. eCollection 2022.
8
Identification of TCR repertoires in asymptomatic COVID-19 patients by single-cell T-cell receptor sequencing.通过单细胞 T 细胞受体测序鉴定无症状 COVID-19 患者的 TCR 谱。
Blood Cells Mol Dis. 2022 Nov;97:102678. doi: 10.1016/j.bcmd.2022.102678. Epub 2022 Jun 2.
9
Mallampati Score Is an Independent Predictor of Active Oxygen Therapy in Patients with COVID-19.马兰帕蒂评分是新冠病毒肺炎患者主动氧疗的独立预测指标。
J Clin Med. 2022 May 24;11(11):2958. doi: 10.3390/jcm11112958.
10
Laboratory medicine in pandemic of COVID-19.新型冠状病毒肺炎大流行中的检验医学。
Biochem Med (Zagreb). 2022 Jun 15;32(2):020501. doi: 10.11613/BM.2022.020501. Epub 2022 Apr 15.